87770658 - AOBIOME THERAPEUTICS

Information

  • Trademark
  • 87770658
  • Serial Number
    87770658
  • Filing Date
    January 25, 2018
    6 years ago
  • Transaction Date
    April 11, 2022
    2 years ago
  • Status Date
    April 11, 2022
    2 years ago
  • Published for Opposition Date
    January 08, 2019
    5 years ago
  • Location Date
    August 18, 2021
    2 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BURDECKI, ANNA C
  • Attorney Docket Number
    N2060-2012
    Attorney Name
    Ann Lamport Hammitte
    Law Office Assigned Location Code
    L80
  • Owners
Mark Drawing Code
3000
Mark Identification
AOBIOME THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of a stylized design consisting of a shaded square with what appears to be part of a sunset composed of small circles. To the right of the stylized design are the words "AOBIOME" and "THERAPEUTICS". The first three letters of the word "AOBIOME" are capitalized, while the rest are lowercase. The word "AOBIOME" sits atop the word "THERAPEUTICS", which is in all capital letters.
  • GS0051: Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0101: Stents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices
  • D10000: "THERAPEUTICS"
Case File Event Statements
  • 4/11/2022 - 2 years ago
    42 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 4/11/2022 - 2 years ago
    41 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 8/19/2021 - 2 years ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/18/2021 - 2 years ago
    39 - EXTENSION 5 GRANTED Type: EX5G
  • 8/16/2021 - 2 years ago
    38 - EXTENSION 5 FILED Type: EXT5
  • 8/18/2021 - 2 years ago
    37 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/16/2021 - 2 years ago
    36 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/11/2021 - 3 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/9/2021 - 3 years ago
    34 - EXTENSION 4 GRANTED Type: EX4G
  • 2/9/2021 - 3 years ago
    33 - EXTENSION 4 FILED Type: EXT4
  • 2/9/2021 - 3 years ago
    32 - TEAS EXTENSION RECEIVED Type: EEXT
  • 9/4/2020 - 3 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/2/2020 - 3 years ago
    30 - EXTENSION 3 GRANTED Type: EX3G
  • 9/2/2020 - 3 years ago
    29 - EXTENSION 3 FILED Type: EXT3
  • 9/2/2020 - 3 years ago
    28 - TEAS EXTENSION RECEIVED Type: EEXT
  • 3/6/2020 - 4 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/4/2020 - 4 years ago
    26 - EXTENSION 2 GRANTED Type: EX2G
  • 3/4/2020 - 4 years ago
    25 - EXTENSION 2 FILED Type: EXT2
  • 3/4/2020 - 4 years ago
    24 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/24/2019 - 4 years ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/22/2019 - 4 years ago
    22 - EXTENSION 1 GRANTED Type: EX1G
  • 7/22/2019 - 4 years ago
    21 - EXTENSION 1 FILED Type: EXT1
  • 7/22/2019 - 4 years ago
    20 - TEAS EXTENSION RECEIVED Type: EEXT
  • 3/5/2019 - 5 years ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/8/2019 - 5 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/8/2019 - 5 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/19/2018 - 5 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/20/2018 - 5 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/20/2018 - 5 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/20/2018 - 5 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/20/2018 - 5 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/20/2018 - 5 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/13/2018 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/13/2018 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/13/2018 - 5 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/15/2018 - 6 years ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 5/15/2018 - 6 years ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 5/15/2018 - 6 years ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 5/7/2018 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/7/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 2/6/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/29/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP